BioMarin Pharmaceutical's GAAP net income for 9 months of 2022 was $141.81 million, compared to a loss of $6.18 million in the previous year. Revenue increased by 11.6% to $1.559 billion from $1.397 billion a year earlier.
BioMarin Pharmaceutical's GAAP net income for 9 months of 2022 was $141.81 million, compared to a loss of $6.18 million in the previous year. Revenue increased by 11.6% to $1.559 billion from $1.397 billion a year earlier. 
investors.biomarin.com
English (US) 